Carter-O'Connell Ian, Cohen Michael S
Program in Chemical Biology, Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon.
Curr Protoc Chem Biol. 2015 Jun 1;7(2):121-39. doi: 10.1002/9780470559277.ch140259.
Poly-ADP-ribose polymerases (PARPs) comprise a family of 17 distinct enzymes that catalyze the transfer of ADP-ribose from nicotinamide adenine dinucleotide (NAD+) to acceptor sites on protein targets. PARPs have been implicated in a number of essential signaling pathways regulating both normal cell function and pathophysiology. To understand the physiological role of each PARP family member in the cell we need to identify the direct targets for each unique PARP in a cellular context. PARP-family member-specific target identification is challenging because of their shared catalytic mechanism and functional redundancy. To address this challenge, we have engineered a PARP variant that efficiently uses an orthogonal NAD+ analog, an analog that endogenous PARPs cannot use, as a substrate for ADP-ribosylation. The protocols in this unit describe a general procedure for using engineered PARP variants-orthogonal NAD+ analog pairs for labeling and identifying the direct targets of the poly-subfamily of PARPs (PARPs 1-3, 5, and 6).
聚(ADP - 核糖)聚合酶(PARP)由17种不同的酶组成,这些酶催化将ADP - 核糖从烟酰胺腺嘌呤二核苷酸(NAD +)转移到蛋白质靶标的受体位点。PARP参与了许多调节正常细胞功能和病理生理学的重要信号通路。为了了解每个PARP家族成员在细胞中的生理作用,我们需要在细胞环境中确定每个独特PARP的直接靶标。由于PARP家族成员具有共同的催化机制和功能冗余性,因此特异性鉴定PARP家族成员的靶标具有挑战性。为了应对这一挑战,我们设计了一种PARP变体,该变体能够有效地使用一种正交NAD +类似物(一种内源性PARP无法使用的类似物)作为ADP - 核糖基化的底物。本单元中的方案描述了使用工程化PARP变体 - 正交NAD +类似物对标记和鉴定PARP多亚家族(PARP 1 - 3、5和6)直接靶标的一般程序。